2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow Effect of Drugs: new trials by email Literature Review of Effect of Drugs trials Research Report on Effect of Drugs
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19 Nintedanib 150 MG, Placebo - COVID-19, Nintedanib | Phase 2 | Unknown | Huilan Zhang | 96 | 2020-04-02 | 2020-04-08 |
| Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic Chordoma Anlotinib Hydrochloride - Effect of Drugs, Quality of Life | Phase 2 | Unknown | Peking University People's Hospital | 60 | 2019-07-18 | 2019-08-05 |
Coronaviridae Infections (1) · Coronavirus Infections (1) · Infections (1) · Lung Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Nidovirales Infections (1) · Pneumonia (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
nintedanib (1)
Huilan Zhang (1) · Peking University People's Hospital (1)
China (1)